Correlation Between Walker Dunlop and ASTELLAS PHARMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Walker Dunlop and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and ASTELLAS PHARMA.

Diversification Opportunities for Walker Dunlop and ASTELLAS PHARMA

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Walker and ASTELLAS is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between Walker Dunlop and ASTELLAS PHARMA

Allowing for the 90-day total investment horizon Walker Dunlop is expected to under-perform the ASTELLAS PHARMA. In addition to that, Walker Dunlop is 1.47 times more volatile than ASTELLAS PHARMA UNSPADR. It trades about -0.24 of its total potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about -0.05 per unit of volatility. If you would invest  945.00  in ASTELLAS PHARMA UNSPADR on November 27, 2024 and sell it today you would lose (45.00) from holding ASTELLAS PHARMA UNSPADR or give up 4.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.31%
ValuesDaily Returns

Walker Dunlop  vs.  ASTELLAS PHARMA UNSPADR

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Walker Dunlop has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, ASTELLAS PHARMA is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Walker Dunlop and ASTELLAS PHARMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and ASTELLAS PHARMA

The main advantage of trading using opposite Walker Dunlop and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.
The idea behind Walker Dunlop and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format